The current study aimed to explore the lived experience of patients with hepatitis C virus
infection. Semi-structured interviews were conducted with seven male participants living with …

Background There has been a paradigm shift in the treatment of Hepatitis C (HCV) from the
interferon-era to direct-acting antiviral (DAA) drugs. Cure of HCV for the key risk group, those …

Проведена оценка уровня стигматизации у 188 больных с ВИЧ-инфекцией. У
большинства больных отмечался умеренный и высокий уровень стигматизации …

Persons who inject illicit drugs are the group most severely affected by the hepatitis C
epidemic but the least likely to receive treatment. Controlling the epidemic will require …

Background Fatigue is a common symptom of chronic hepatitis C virus (HCV) infection and a
frequent side-effect of peginterferon/ribavirin (PR) therapy for HCV. This study evaluated the …

Objectives Many patients with chronic hepatitis C virus (HCV) infection are unaware of their
status. Screening could identify patients at earlier stages of disease, when interventions …

Stigma is one of the main problems of patients suffering from cirrhosis, and it causes many
challenges for the patients and their treatment. The present study aimed to discover and …

Although the adverse impacts of health‐related stigma are well established, there is growing
evidence to suggest that some people reject stigma and become empowered through …

In a growing body of social research it is suggested that hepatitis C virus (HCV) infection is a
low priority for people who inject drugs. We expand on the evidence to explore the link …

Abstract Background The use of Hepatitis C (HCV) NAT positive allografts remains unusual
and is clustered at few centers. We conducted a contemporary literature review to assess …